142 related articles for article (PubMed ID: 9126162)
1. Adenovirus-mediated gene transfer to the central nervous system for Parkinson's disease.
Horellou P; Sabaté O; Buc-Caron MH; Mallet J
Exp Neurol; 1997 Mar; 144(1):131-8. PubMed ID: 9126162
[TBL] [Abstract][Full Text] [Related]
2. In vivo adenovirus-mediated gene transfer for Parkinson's disease.
Horellou P; Bilang-Bleuel A; Mallet J
Neurobiol Dis; 1997; 4(3-4):280-7. PubMed ID: 9361305
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
4. [Gene therapy of neurological diseases].
Kahn A; Haase G; Akli S; Guidotti JE
C R Seances Soc Biol Fil; 1996; 190(1):9-11. PubMed ID: 8881264
[TBL] [Abstract][Full Text] [Related]
5. Recombinant adenovirus: a gene transfer vector for study and treatment of CNS diseases.
Davidson BL; Bohn MC
Exp Neurol; 1997 Mar; 144(1):125-30. PubMed ID: 9126161
[TBL] [Abstract][Full Text] [Related]
6. Gene therapeutic strategies for neurodegenerative diseases.
Baekelandt V; De Strooper B; Nuttin B; Debyser Z
Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
[TBL] [Abstract][Full Text] [Related]
7. Application of ex vivo gene therapy in the treatment of Parkinson's disease.
Raymon HK; Thode S; Gage FH
Exp Neurol; 1997 Mar; 144(1):82-91. PubMed ID: 9126156
[TBL] [Abstract][Full Text] [Related]
8. Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease.
Bowers WJ; Howard DF; Federoff HJ
Exp Neurol; 1997 Mar; 144(1):58-68. PubMed ID: 9126153
[TBL] [Abstract][Full Text] [Related]
9. Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector.
Deng W; Bivalacqua TJ; Chattergoon NN; Jeter JR; Kadowitz PJ
Stem Cells; 2004; 22(7):1279-91. PubMed ID: 15579646
[TBL] [Abstract][Full Text] [Related]
10. Use of growth factors for the treatment of Parkinson's disease.
Yasuda T; Mochizuki H
Expert Rev Neurother; 2010 Jun; 10(6):915-24. PubMed ID: 20518608
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy.
Capowski EE; Schneider BL; Ebert AD; Seehus CR; Szulc J; Zufferey R; Aebischer P; Svendsen CN
J Neurosci Methods; 2007 Jul; 163(2):338-49. PubMed ID: 17397931
[TBL] [Abstract][Full Text] [Related]
12. Prospects for gene therapy in Parkinson's disease.
Freese A; Stern M; Kaplitt MG; O'Connor WM; Abbey MV; O'Connor MJ; During MJ
Mov Disord; 1996 Sep; 11(5):469-88. PubMed ID: 8866488
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for Parkinson's disease.
Horellou P; Mallet J
Mol Neurobiol; 1997 Oct; 15(2):241-56. PubMed ID: 9396012
[TBL] [Abstract][Full Text] [Related]
14. Overcoming cellular immunity to prolong adenoviral-mediated gene expression in sciatic nerve.
Jani A; Menichella D; Jiang H; Chbihi T; Acsadi G; Kamholz J; Shy ME
Ann N Y Acad Sci; 1999 Sep; 883():397-414. PubMed ID: 10586264
[TBL] [Abstract][Full Text] [Related]
15. Recombinant AAV-mediated gene delivery to the central nervous system.
Tenenbaum L; Chtarto A; Lehtonen E; Velu T; Brotchi J; Levivier M
J Gene Med; 2004 Feb; 6 Suppl 1():S212-22. PubMed ID: 14978764
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain.
Kojima H; Abiru Y; Sakajiri K; Watabe K; Ohishi N; Takamori M; Hatanaka H; Yagi K
Biochem Biophys Res Commun; 1997 Sep; 238(2):569-73. PubMed ID: 9299553
[TBL] [Abstract][Full Text] [Related]
17. Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter.
Navarro V; Millecamps S; Geoffroy MC; Robert JJ; Valin A; Mallet J; Gal La Salle GL
Gene Ther; 1999 Nov; 6(11):1884-92. PubMed ID: 10602384
[TBL] [Abstract][Full Text] [Related]
18. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
19. Current development of adeno-associated viral vectors.
Romano G
Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration.
Blits B; Boer GJ; Verhaagen J
Cell Transplant; 2002; 11(6):593-613. PubMed ID: 12428749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
